Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)
Public ClinicalTrials.gov record NCT04484142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Single-arm, Open-label Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations and Progressed On or After Applicable Targeted Therapy and Platinum Based Chemotherapy (TROPION-Lung05)
Study identification
- NCT ID
- NCT04484142
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 137 participants
Conditions and interventions
Conditions
Interventions
- DS-1062a Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2021
- Primary completion
- Mar 9, 2023
- Completion
- Feb 3, 2026
- Last update posted
- Mar 23, 2026
2021 – 2026
United States locations
- U.S. sites
- 28
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85259 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| UCLA | Santa Monica | California | 90404 | — |
| Boca Raton Regional Hospital | Boca Raton | Florida | 33486 | — |
| Sarah Cannon Research Institute at Florida Cancer Center, North | Gainesville | Florida | 32605 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| AdventHealth Orlando | Orlando | Florida | 32804 | — |
| Sarah Cannon Research Institute at Florida Cancer Center, South | Port Charlotte | Florida | 33980 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| The Office of Dr. Frederick P. Smith MD | Chevy Chase | Maryland | 20815 | — |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| University of Michigan | Detroit | Michigan | 48202 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| XCancer / Regional Cancer Care Associate (Astera) | East Brunswick | New Jersey | 08816 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| New York Cancer and Blood Specialists | Port Jefferson | New York | 11776 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Avera Cancer Institute Sioux Falls | Sioux Falls | South Dakota | 57105 | — |
| Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga | Chattanooga | Tennessee | 37404 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Virginia Cancer Specialists | Athens | Virginia | 30607 | — |
| Kadlec Clinic Hematology and Oncology | Kennewick | Washington | 99336 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 33612 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04484142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04484142 live on ClinicalTrials.gov.